FDA: EUAs for COVID-19 Lab Tests Will Continue after PHE Ends
Agency says it will continue to have authority to clear new lab tests and other COVID-19 products on an emergency basis even after the PHE ends.
FDA-nir
Subscribe today for access to
Articles and Reports
Empowered Dx in Hot Water with FDA Again Over COVID-19 Test Kits
At the end of 2022, the agency sent a new warning letter to Empowered for unauthorized distribution of COVID-19 test kits.
FDA Tightens the Screws on EUA Review of COVID-19 Tests
The agency recently announced subtle but significant changes to its policies governing review of new lab tests for COVID-19.
FDA Approves First Liquid Biopsy Companion Diagnostic for Lung Cancer
From - National Intelligence Report
Roche announced last week that the U.S. Food and Drug Administration (FDA) approved the cobas® EGFR Mutation Test v2 "for use with…
House Appropriations Bill Seeks to Halt FDA Regulation of LDTs
...
Already a member? Log in here
First Commercial Lab Gets FDA Emergency Clearance for Zika Test
...
Already a member? Log in here
Culture-Independent Tests Gain Clinical Traction, Hamper Public Health
...
Already a member? Log in here
U.S. Government Begins Prepping Battle Against Zika with National Summit
From - National Intelligence Report
With spring and mosquito season rapidly approaching, concern about and the fight against the Zika virus is heating up. Today, a press conference will be…
FDA Challenges DTC Genomic Tests from Startup Labs
...
Already a member? Log in here
New FDA Approvals, Guidelines and Letters Address Zika Testing
...
Already a member? Log in here
AACC Weighs in on Regulation of Laboratory Developed Tests
...
Already a member? Log in here